about
Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group.Improvement of the initial management of sarcomas after the dissemination of evidence-based guidelines depends on the primary sarcoma location: a population-based studySorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO).Cystic lymph node metastases of head and neck squamous cell carcinoma: pitfalls and controversies.Frequency of certain established risk factors in soft tissue sarcomas in adults: a prospective descriptive study of 658 casesAngiosarcoma: state of the art and perspectives.The long non-coding RNA 91H increases aggressive phenotype of breast cancer cells and up-regulates H19/IGF2 expression through epigenetic modifications.Malignant Peripheral Nerve Sheath Tumor Is a Challenging Diagnosis: A Systematic Pathology Review, Immunohistochemistry, and Molecular Analysis in 160 Patients From the French Sarcoma Group Database.Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France.EGFR-Mutated Breast Metastasis of Lung Adenocarcinoma: A Case Report.Combined Mass Spectrometry Imaging and Top-down Microproteomics Reveals Evidence of a Hidden Proteome in Ovarian Cancer.Solitary fibrous tumors and so-called hemangiopericytoma.Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?Surgical implications of sentinel node with micrometastatic disease in invasive breast cancer.Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trial.Presentation and outcome of frequent and rare sarcoma histologic subtypes: A study of 10,262 patients with localized visceral/soft tissue sarcoma managed in reference centers.Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO).Pure flat epithelial atypia: is there a place for routine surgery?[Neuroendocrine tumors of the breast: Myth or reality? A systematic review].[Intraoperative molecular assessment of sentinel nodes in the breast cancer using the Gene Search BLN Assay technique: our experience about 126 patients].Assessment of human epidermal growth factor receptor 2 status in urothelial carcinoma of the upper urinary tract: a study using dual-color in situ hybridization and immunohistochemistry.Long-term recurrence of soft tissue sarcomas: Prognostic factors and implications for prolonged follow-upPrognostic factors and impact of adjuvant treatments on local and metastatic relapse of soft-tissue sarcoma patients in the competing risks settingMetastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcomeAdult-type rhabdomyosarcoma: analysis of 57 cases with clinicopathologic description, identification of 3 morphologic patterns and prognosis.Renal tubular dysgenesis-like lesions and hypocalvaria. Report of two cases involving indomethacin[Mammary pilomatrixoma clinically mimicking carcinoma][Frequency of genetic diseases and cancer antecedents in 493 adults with visceral or soft tissue sarcomas]Prognostic factors for adult sarcomas of head and neck[Breast adenocarcinoma: critical analysis of sentinel lymph node histopathological results of 542 procedures][Intraoperative determination of axillary node metastasis by RT-PCR]Soft tissue sarcomas of the trunk wall (STS-TW): a study of 343 patients from the French Sarcoma Group (FSG) databasePulmonary blastoma in adult: dramatic but transient response to doxorubicin plus ifosfamideIs there a reliable method to assess the complete pathologic response on the tumor after neo-adjuvant chemotherapy in inflammatory breast cancer toward recommendations for the pathologic process? Experience in 56 patients treated in a single instituPredictive factors of positive circumferential resection margin after radiochemotherapy for rectal cancer: the French randomised trial ACCORD12/0405 PRODIGE 2Localised angiosarcomas: the identification of prognostic factors and analysis of treatment impact. A retrospective analysis from the French Sarcoma Group (GSF/GETO)CSF CA 15-3 in breast cancer-related leptomeningeal metastasesPerfusion MR imaging at 3-Tesla: Can it predict tumor grade and histologic necrosis rate of musculoskeletal sarcoma?Variation of early auditory evoked potentials (EAEP) in severe hyponatremia
P50
Q34602033-BBD5E0C5-42EB-4F1D-A24B-2A65F15C8026Q35583853-DAF5D2E9-3FC9-4FAC-BD31-F2076E33F175Q35776264-E046EC0C-7E25-46BB-8780-1BD74358DFBCQ36080979-C2A8C310-1FDE-44F3-B26B-600BAB7E114CQ36662584-62BAA034-47C6-41A7-A4FC-8CD973927068Q37807628-4F1D5335-28B0-45C1-B486-477850A9D2DBQ38735783-330C835E-ECC4-45B0-B9C9-044539660FA0Q38829522-3FDFED4A-AE7A-4979-8CDA-5588F5518D40Q38895449-FF134B29-BA13-4A96-A23C-1B32BE7F81D9Q39258492-A4462E3F-C79D-4313-BA85-8EA84837AF9AQ41040816-E6055073-159E-4080-8123-EB0744DAC111Q42137004-BF5AB336-9401-4CA2-9A84-947924078371Q43732463-71A989DE-5877-49EA-A7F6-E0C9E3602110Q45119060-C724FA61-5552-4A71-9C1F-B8EE095BA952Q46138405-A23B3036-B0E6-4F17-8D4D-44714A797484Q48168012-D7126504-A94F-4AA3-B226-DE970AB202DFQ51066747-23693DC9-A8FC-416B-91D1-408B748F41A0Q51208462-F9E83389-30D8-46FE-96EE-9947E7A0B694Q52642115-A126631A-986A-4E18-A5B3-F24219400501Q53081181-C4AB62E9-278A-4F8A-9AE9-7EA2040DE499Q54517927-D103EA8F-1C9D-4101-9E0D-9AFFA073A2C5Q57570645-CDDA8C81-1BE2-4338-AC7C-814C48EE8D6BQ57570648-6A0E439E-A351-4580-98F7-2FC8BAC260A8Q57570849-6F8BAF0A-9B0B-453A-9F39-41E579B4E38AQ64974533-984740C0-6D0F-4DC1-BB1A-D828C6EC0D4BQ73458104-A0249241-6E3F-46C6-AB16-28D885C110CAQ73695507-F0F01098-19E7-4F55-A96B-49050DDCD58DQ75224290-A45DE168-408A-486B-A3E6-DDCDBBB6D0B0Q80878405-4892930D-4027-4FF6-AEBB-CB5AED6B5692Q81550295-F130C4B3-7E25-4C0E-AF40-DDDA13A55E61Q82741069-0DDD0141-200E-4321-B3B5-97382E0B8EF1Q83264470-364DB14C-63C4-406B-958F-948FEBF59981Q84615475-810995EE-4971-484B-90EB-91A4360DC1E5Q84769911-8FE564BB-8010-44F4-A142-B914559D7303Q84837964-C3DE4CD4-A960-449C-850A-E4E060831569Q84961479-C04E37EB-F3CA-4241-A745-20D8264504B9Q87176290-DE3C893F-559B-4B4E-A32B-974F15B6CA56Q88150510-53E69E5F-60B2-478F-A7FB-3C39B13A1C31Q93554623-34D35D51-2BAB-49EE-A9A0-4134A6292BBB
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-4227-6545
@en
name
Yves-Marie Robin
@ast
Yves-Marie Robin
@en
Yves-Marie Robin
@es
Yves-Marie Robin
@nl
type
label
Yves-Marie Robin
@ast
Yves-Marie Robin
@en
Yves-Marie Robin
@es
Yves-Marie Robin
@nl
prefLabel
Yves-Marie Robin
@ast
Yves-Marie Robin
@en
Yves-Marie Robin
@es
Yves-Marie Robin
@nl
P106
P31
P496
0000-0002-4227-6545